GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Current Accrued Expense

Origin Therapeutics Holdings (XCNQ:ORIG) Current Accrued Expense : C$0.00 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Current Accrued Expense?

Origin Therapeutics Holdings's Current Accrued Expense for the quarter that ended in Jun. 2023 was C$0.00 Mil.


Origin Therapeutics Holdings Current Accrued Expense Historical Data

The historical data trend for Origin Therapeutics Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Current Accrued Expense Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Current Accrued Expense
- -

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only - - - - -

Origin Therapeutics Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Origin Therapeutics Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines

From GuruFocus

Third Avenue Management Comments on Ocean Rig UDW

By Holly LaFon Holly LaFon 11-01-2018

Bullish Developments Continue For Ocean Rig

By Faisal Humayun Faisal Humayun 06-30-2014

Strong Results Makes Ocean Rig Attractive

By Faisal Humayun Faisal Humayun 11-10-2014

3 Reasons to Buy an Ocean Rig

By Subia Khan Value Investor 04-04-2014

Paul Singer's 6 Largest New Holdings

By Sydnee Gatewood Sydnee Gatewood 11-28-2017